These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 21641386)

  • 1. β-cell loss and β-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition.
    Jurgens CA; Toukatly MN; Fligner CL; Udayasankar J; Subramanian SL; Zraika S; Aston-Mourney K; Carr DB; Westermark P; Westermark GT; Kahn SE; Hull RL
    Am J Pathol; 2011 Jun; 178(6):2632-40. PubMed ID: 21641386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Islet amyloid polypeptide in pancreatic islets from type 2 diabetic subjects.
    Tomita T
    Islets; 2012; 4(3):223-32. PubMed ID: 22847497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet amyloid with macrophage migration correlates with augmented β-cell deficits in type 2 diabetic patients.
    Kamata K; Mizukami H; Inaba W; Tsuboi K; Tateishi Y; Yoshida T; Yagihashi S
    Amyloid; 2014 Sep; 21(3):191-201. PubMed ID: 25007035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid formation reduces protein kinase B phosphorylation in primary islet β-cells which is improved by blocking IL-1β signaling.
    Zhang Y; Warnock GL; Ao Z; Park YJ; Safikhan N; Ghahary A; Marzban L
    PLoS One; 2018; 13(2):e0193184. PubMed ID: 29474443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-9 reduces islet amyloid formation by degrading islet amyloid polypeptide.
    Aston-Mourney K; Zraika S; Udayasankar J; Subramanian SL; Green PS; Kahn SE; Hull RL
    J Biol Chem; 2013 Feb; 288(5):3553-9. PubMed ID: 23229548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional differences in islet amyloid deposition in the residual pancreas with new-onset diabetes secondary to pancreatic ductal adenocarcinoma.
    Wang R; Liu Y; Liang Y; Zhou L; Chen MJ; Liu XB; Tan CL; Chen YH
    World J Gastrointest Surg; 2023 Aug; 15(8):1703-1711. PubMed ID: 37701698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neprilysin impedes islet amyloid formation by inhibition of fibril formation rather than peptide degradation.
    Zraika S; Aston-Mourney K; Marek P; Hull RL; Green PS; Udayasankar J; Subramanian SL; Raleigh DP; Kahn SE
    J Biol Chem; 2010 Jun; 285(24):18177-83. PubMed ID: 20400513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix Metalloproteinase-9 Protects Islets from Amyloid-induced Toxicity.
    Meier DT; Tu LH; Zraika S; Hogan MF; Templin AT; Hull RL; Raleigh DP; Kahn SE
    J Biol Chem; 2015 Dec; 290(51):30475-85. PubMed ID: 26483547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes.
    Huang CJ; Lin CY; Haataja L; Gurlo T; Butler AE; Rizza RA; Butler PC
    Diabetes; 2007 Aug; 56(8):2016-27. PubMed ID: 17475933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic islet amyloidosis, beta-cell apoptosis, and alpha-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons.
    Guardado-Mendoza R; Davalli AM; Chavez AO; Hubbard GB; Dick EJ; Majluf-Cruz A; Tene-Perez CE; Goldschmidt L; Hart J; Perego C; Comuzzie AG; Tejero ME; Finzi G; Placidi C; La Rosa S; Capella C; Halff G; Gastaldelli A; DeFronzo RA; Folli F
    Proc Natl Acad Sci U S A; 2009 Aug; 106(33):13992-7. PubMed ID: 19666551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation.
    Park YJ; Warnock GL; Ao Z; Safikhan N; Meloche M; Asadi A; Kieffer TJ; Marzban L
    Diabetes Obes Metab; 2017 May; 19(5):682-694. PubMed ID: 28058779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid formation disrupts the balance between interleukin-1β and interleukin-1 receptor antagonist in human islets.
    Hui Q; Asadi A; Park YJ; Kieffer TJ; Ao Z; Warnock GL; Marzban L
    Mol Metab; 2017 Aug; 6(8):833-844. PubMed ID: 28752047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid.
    Butler AE; Janson J; Soeller WC; Butler PC
    Diabetes; 2003 Sep; 52(9):2304-14. PubMed ID: 12941770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet Amyloid in Patients With Diabetes Due to Exocrine Pancreatic Disorders, Type 2 Diabetes, and Nondiabetic Patients.
    Ueberberg S; Nauck MA; Uhl W; Montemurro C; Tannapfel A; Clark A; Meier JJ
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32271378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulated pancreatic tissue microRNA-375 associates with human type 2 diabetes through beta-cell deficit and islet amyloid deposition.
    Zhao H; Guan J; Lee HM; Sui Y; He L; Siu JJ; Tse PP; Tong PC; Lai FM; Chan JC
    Pancreas; 2010 Aug; 39(6):843-6. PubMed ID: 20467341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The S20G substitution in hIAPP is more amyloidogenic and cytotoxic than wild-type hIAPP in mouse islets.
    Meier DT; Entrup L; Templin AT; Hogan MF; Mellati M; Zraika S; Hull RL; Kahn SE
    Diabetologia; 2016 Oct; 59(10):2166-71. PubMed ID: 27393137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between amyloid toxicity in alpha and beta cells in human and mouse islets and the role of caspase-3.
    Law E; Lu S; Kieffer TJ; Warnock GL; Ao Z; Woo M; Marzban L
    Diabetologia; 2010 Jul; 53(7):1415-27. PubMed ID: 20369225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta cell death in the islet of Langerhans and the progression from normal glucose tolerance to type 2 diabetes in non-human primates (baboon, Papio hamadryas).
    Guardado Mendoza R; Perego C; Finzi G; La Rosa S; Capella C; Jimenez-Ceja LM; Velloso LA; Saad MJ; Sessa F; Bertuzzi F; Moretti S; Dick EJ; Davalli AM; Folli F
    Diabetologia; 2015 Aug; 58(8):1814-26. PubMed ID: 26049399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreas Atrophy and Islet Amyloid Deposition in Patients With Elderly-Onset Type 2 Diabetes.
    Xin A; Mizukami H; Inaba W; Yoshida T; Takeuchi YK; Yagihashi S
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3162-3171. PubMed ID: 28505316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet microangiopathy and augmented β-cell loss in Japanese non-obese type 2 diabetes patients who died of acute myocardial infarction.
    Takahashi K; Mizukami H; Osonoi S; Takeuchi Y; Kudoh K; Sasaki T; Daimon M; Yagihashi S
    J Diabetes Investig; 2021 Dec; 12(12):2149-2161. PubMed ID: 34032392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.